Ascendis Pharma A/S (ASND) Competitors

argenx (NASDAQ:ARGX) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

Does the MarketBeat Community favor ARGX or ASND?

argenx received 209 more outperform votes than Ascendis Pharma A/S when rated by MarketBeat users. Likewise, 67.38% of users gave argenx an outperform vote while only 66.87% of users gave Ascendis Pharma A/S an outperform vote.

Company	Underperform	Outperform
argenx	Outperform Votes 657 67.38%	Underperform Votes 318 32.62%
Ascendis Pharma A/S	Outperform Votes 448 66.87%	Underperform Votes 222 33.13%

Which has better earnings & valuation, ARGX or ASND?

argenx has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than argenx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
argenx	$2.19B	16.58	-$295.05M	$12.59	47.23
Ascendis Pharma A/S	$363.64M	26.52	-$409.12M	-$7.10	-22.27

Is ARGX or ASND more profitable?

argenx has a net margin of -2.11% compared to Ascendis Pharma A/S's net margin of -104.54%. Ascendis Pharma A/S's return on equity of 0.00% beat argenx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
argenx	-2.11%	-1.45%	-1.29%
Ascendis Pharma A/S	-104.54%	N/A	-39.23%

Which has more volatility & risk, ARGX or ASND?

argenx has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500.

Does the media refer more to ARGX or ASND?

In the previous week, argenx had 2 more articles in the media than Ascendis Pharma A/S. MarketBeat recorded 17 mentions for argenx and 15 mentions for Ascendis Pharma A/S. argenx's average media sentiment score of 1.18 beat Ascendis Pharma A/S's score of 1.06 indicating that argenx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
argenx	10 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Ascendis Pharma A/S	10 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate ARGX or ASND?

argenx presently has a consensus target price of $699.28, suggesting a potential upside of 17.59%. Ascendis Pharma A/S has a consensus target price of $204.67, suggesting a potential upside of 29.42%. Given Ascendis Pharma A/S's stronger consensus rating and higher probable upside, analysts clearly believe Ascendis Pharma A/S is more favorable than argenx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
argenx	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.91
Ascendis Pharma A/S	0 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.93

Do institutionals & insiders hold more shares of ARGX or ASND?

60.3% of argenx shares are owned by institutional investors. 2.4% of argenx shares are owned by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

argenx beats Ascendis Pharma A/S on 13 of the 19 factors compared between the two stocks.